Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2015 16:01 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Reports Fiscal Third Quarter 2015 Financial and Business Results

NEW YORK, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today reported results for its third fiscal quarter ended June 30,...
August 05, 2015 08:00 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer

NEW YORK, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company announced today that Jason S. Slakter, MD, has been appointed Chief...
July 30, 2015 08:00 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical to Report Third Quarter 2015 Financial and Business Results on Thursday, August 6

NEW YORK, July 30, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it will report financial results for the...
July 13, 2015 07:30 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Announces Positive Results of a Phase II Clinical Study for OHR-102 in Retinal Vein Occlusion

NEW YORK, July 13, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced positive final results from a Phase II...
May 11, 2015 16:01 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Reports Fiscal Second Quarter 2015 Financial and Business Results

NEW YORK, May 11, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today reported results for its second fiscal quarter ended March...
May 11, 2015 08:00 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical to Report Second Quarter 2015 Financial and Business Results on Monday, May 11

NEW YORK, May 11, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it will report financial results for the...
May 07, 2015 07:00 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Presents Data From OHR-102 Phase II IMPACT Study in Wet-AMD at ARVO Conference

Visual Acuity Benefits Demonstrated in Classic CNV Containing Lesions Data Support a Phase III Development Program in an Optimized Wet-AMD Patient Population NEW YORK, May 7, 2015 (GLOBE...
April 30, 2015 08:00 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical to Present at the 2015 Association for Research in Vision and Ophthalmology (ARVO) Conference in Denver, CO

NEW YORK, April 30, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, announced today the details of two podium presentations at the...
March 27, 2015 07:00 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Announces Final Topline Data From OHR-102 Phase II IMPACT Study in Wet-AMD

Positive Visual Acuity Benefit in Classic Containing CNV Using OHR-102 Combination Therapy Conference Call to Discuss Results at 8:00 AM EDT Today NEW YORK, March 27, 2015 (GLOBE NEWSWIRE) --...
March 03, 2015 08:00 ET | Source: Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical to Present at the 35th Annual Cowen & Company Health Care Conference

NEW YORK, March 3, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that Dr. Irach Taraporewala, Chief Executive...